Jordan vs Slovenia: The number of people with susceptibility test result for rifampicin
Jordan
62
in 2021
Slovenia
58
in 2021
Jordan rank
117th
Slovenia rank
119th
The number of people with susceptibility test result for rifampicin over time
- Jordan
- Slovenia
How they compare
Jordan currently reports 62 against 58 in Slovenia, a difference of 4.
That makes Jordan's figure about 1.1 times Slovenia's.
The two have swapped places 3 times across 5 shared years of data; in 2017 it was Slovenia ahead.
Jordan ranks 117th and Slovenia ranks 119th of 155 countries.
Jordan has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Jordan | Slovenia | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 84.33 | 77.67 | 6.67 | Jordan |
| 2020s | 86 | 57.5 | 28.5 | Jordan |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher the number of people with susceptibility test result for rifampicin, Jordan or Slovenia?
- Jordan, at 62 against 58 in Slovenia as of 2021.
- What is the difference in the number of people with susceptibility test result for rifampicin between Jordan and Slovenia?
- 4, with Jordan ahead.
- How many years of comparable data are there for Jordan and Slovenia?
- 5 years are reported by both, from 2017 to 2021.
- How do Jordan and Slovenia rank globally for the number of people with susceptibility test result for rifampicin?
- Jordan ranks 117th and Slovenia ranks 119th of 155 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.. Statizoid refreshes it automatically from the source and publishes the full history for both places.